These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8949251)

  • 21. Clinical magnetic resonance spectroscopy of the central nervous system.
    Ratai EM; Gilberto González R
    Handb Clin Neurol; 2016; 135():93-116. PubMed ID: 27432661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MR spectroscopy: its potential role for drug development for the treatment of psychiatric diseases.
    Mason GF; Krystal JH
    NMR Biomed; 2006 Oct; 19(6):690-701. PubMed ID: 16986118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [N-acetylaspartate is a biomarker of psychiatric and neurological disorders].
    Baymeeva NV; Miroshnichenko II
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):94-98. PubMed ID: 26356622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance spectroscopy for studies of neurotransmission in vivo.
    Mason GF
    Psychopharmacol Bull; 2003; 37(2):26-40. PubMed ID: 14566212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonace imaging study in major psychiatric disorders.
    Lalitanantpong D; Lalitanantpong S
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S300-8. PubMed ID: 16083207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton magnetic resonance spectroscopy in Alzheimer's disease, a review.
    Loos C; Achten E; Santens P
    Acta Neurol Belg; 2010 Dec; 110(4):291-8. PubMed ID: 21305856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perfusion magnetic resonance imaging in psychiatry.
    Théberge J
    Top Magn Reson Imaging; 2008 Apr; 19(2):111-30. PubMed ID: 19363433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Utility of Magnetic Resonance Spectroscopy for Understanding Substance Use Disorders: A Systematic Review of the Literature.
    Hellem T; Shi X; Latendresse G; Renshaw PF
    J Am Psychiatr Nurses Assoc; 2015; 21(4):244-75. PubMed ID: 26282670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiparametric Imaging Analysis: Magnetic Resonance Spectroscopy.
    Rapalino O; Ratai EM
    Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):671-686. PubMed ID: 27742109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of non-invasive neuroradiological methods in research of psychoactive drugs.
    Henigsberg N; Kovacić Z; Kalember P
    Psychiatr Danub; 2007 Sep; 19(3):234-7. PubMed ID: 17914326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proton magnetic resonance spectroscopy in pediatric neuroradiology.
    Moore GJ
    Pediatr Radiol; 1998 Nov; 28(11):805-14. PubMed ID: 9799306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance spectroscopic methods for the assessment of metabolic functions in the diseased brain.
    Hall H; Cuellar-Baena S; Dahlberg C; In't Zandt R; Denisov V; Kirik D
    Curr Top Behav Neurosci; 2012; 11():169-98. PubMed ID: 22076698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of magnetic resonance spectroscopy in evaluation of congenital/developmental brain abnormalities.
    Shekdar K; Wang DJ
    Semin Ultrasound CT MR; 2011 Dec; 32(6):510-38. PubMed ID: 22108216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnetic resonance spectroscopy studies of GABA in neuropsychiatric disorders.
    Chang L; Cloak CC; Ernst T
    J Clin Psychiatry; 2003; 64 Suppl 3():7-14. PubMed ID: 12662128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Images of the brain: past as prologue.
    Wagner HN
    J Nucl Med; 1986 Dec; 27(12):1929-37. PubMed ID: 3023564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-acetyl-aspartate (NAA) as a correlate of pharmacological treatment in psychiatric disorders: a systematic review.
    Paslakis G; Träber F; Roberz J; Block W; Jessen F
    Eur Neuropsychopharmacol; 2014 Oct; 24(10):1659-75. PubMed ID: 25130303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton magnetic resonance spectroscopy as a probe into the pathophysiology of autism spectrum disorders (ASD): a review.
    Baruth JM; Wall CA; Patterson MC; Port JD
    Autism Res; 2013 Apr; 6(2):119-33. PubMed ID: 23436782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Magnetic resonance spectroscopy in schizophrenia].
    Delamillieure P; Constans JM; Fernandez J; Dollfus S
    Encephale; 2000; 26(1):21-31. PubMed ID: 10875059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leptin as a neuroactive agent.
    Zupancic ML; Mahajan A
    Psychosom Med; 2011 Jun; 73(5):407-14. PubMed ID: 21597032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton MRS and MRSI of the brain without water suppression.
    Dong Z
    Prog Nucl Magn Reson Spectrosc; 2015 Apr; 86-87():65-79. PubMed ID: 25919199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.